مجله اخلاق زیستی- علمی پژوهشی

Rahbarpour M. The concept of bioethics and its scope. Bioethics Quarterly. 2011; 1(1): 13-48. [Persian]

Rahnama H. Bioethics and transgenic products. Ethics in Science and Technology Quarterly. 2008; 3(1-2): 1-14. [Persian]

Hadjantonakis AK, Papaioannou VE. Can mammalian cloning combined with embryonic stem cell technologies be used to treat human diseases? Genome biology. 2002; 3(8):1-6.

Hwang WS, Roh SI, Lee BC, Kang SK, Kwon DK, Kim S, et al. Patient-specific embryonic stem cells derived from human SCNT blastocysts. Science. 2005; 308(5729): 1777-1783.

Robertson JA. Embryo Stem Cell Research: Ten Years of Controversy. The Journal of Law, Medicine & Ethics. 2010; 2(38): 191-203.

Rhind SM, Taylor JE, De Sousa PA, King TJ, McGarry MW. Human cloning: Can it be made safe?. Nature Rev Genet. 2003; 4(11): 55-64.

Wilmut I, Beaujean N, De Sousa PA, Dinnyes A, King TJ, Paterson LA, Wells DN, Young LE. Somatic cell nuclear transfer. Nature. 2002; 419(6907): 583-587.

Gorbannia N. Regarding the Universal Declaration of Bioethics and Human Rights. Ethics in Science and Technology Quarterly. 2009; 4(1): 133-137. [Persian]

Straus SB, Tan HM, Boerjan W. Strangled at Birth? Forest Biotech and the Convention on Biological Diversity. Nature Biotecnology. 2009; 27(6): 519-527.

West C. Economics and Ethics in the Genetic Engineering of Animals. Harvard Journal of Law and Biotechnology. 2006; 19(2): 413-442.

Tladi D. Civil liability in the Context of the Cartagena Protocol to be or not to be (Binding)? International Environmental Agreements. Politics Law and Economics. 2010; 10(1): 15-27.

Ghareyazi B, Mottaghi A, Vishlaghi N, Rashedi H. Biosafety at International Agreements/ Organizations. Medical Law Quarterly. 2010; 4(12): 131-147. [Persian]

Bell DE. Need for a Biosafety Protocol Finally Agreed upon. Times. 1995; 28: 31-38.

Jordan WC, Verspoor E, Youngson AF. The Effect of Natural Selection on Estimates of Genetic Divergence among Populations of the Atlantic salmon. Journal of Fish Biology.1997; 51(3): 546-560.

Annas GJ, Andrews LB, Isasi RM. Protecting the endangered human: toward an international treaty prohibiting cloning and inheritable alterations. American journal of law & medicine. 2002; 28(2-3):151-78.

Ranjbarian AH, Seif Z. Human Rights Challenges of Human Simulation. Law Journal. 2018; 39(1): 129-158. [Persian]

Naqibzadeh A. The impact of changes in the international system on the concept of human rights. Political and Economic Information Monthly. 2001; 95(171-172): 30-41. [Persian]

Bossart J, Pearson B. Commercialization of gene therapy-the evolution of licensing and rights issues. Trends in biotechnology. 1995; 13(8): 290-294.

Marks SP. Human rights assumptions of restrictive and permissive approaches to human reproductive cloning. Health & Hum. Rts. 2002; 6: 80.

De Sá Mde F, de Oliveiro Naves BT. Embryonic stem cell research in Brazil and the (UN) constitutionality of article 5 of the biosafety act (Part I). Revista de Derecho y Genoma Humano= Law and the Human Genome Review. 2008; 1(28):177-191.

Abbasi M. Human simulation is a new challenge to ethics and human rights. Medical Law Quarterly. 2008; 5(7): 11-46. [Persian]

Epstein G. Controlling Biological Warfare Threats. Critical Reviews in Microbiology. 2001; 27(4): 321-354.

Ghorbani AA. Human Cloning and Criminal Policy. Medical Law Quarterly. 2010; 4(13): 161-190. [Persian]